ConductScience.org, home

Trial · NCT04470310

Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination

NCT04470310, Phase 4, Unknown, Seoul National University Hospital

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination. Trials, record NCT04470310. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04470310

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination
NCT number
NCT04470310
Status
Unknown
Phases
Phase 4
Enrollment
99 participants, actual
Lead sponsor
Seoul National University Hospital
Conditions
Type 2 Diabetes Mellitus
Interventions
Glimepiride, Alogliptin 25Mg Tab, Alogliptin-Pioglitazone 25 Mg-15 Mg Oral Tablet
First posted
2020-07-14
Last updated
2020-10-22

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryHbA1cBaseline, Week 24The change in the mean level of HbA1c from baseline at week 24
SecondaryHbA1c and fasting plasma glucoseBaseline, Week 12, Week 24The change in the mean level of HbA1c at week 12 and mean FPG( fasting plasma glucose) levels
SecondaryThe change in parameters of glycemic variability assessed by CGM from the Baseline at week 24Baseline, Week 24
The change in parameters of glycemic variability assessed by CGM from baseline at week 24: SD(standard deviation), MAGE(Mean Amplitude of Glycaemic Excursions); MODD(Mean of Daily Differences); ADDR(Average Daily Risk Range), M-value
SecondaryThe change in lipid profile from baseline at week 12 and 24Baseline, Week 12, Week 24The average change in the lipid profile: Total cholesterol (mg/dL), Triglyceride(mg/dL), HDL-cholesterol, (mg/dL) LDL cholesterol (mg/dL)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04470310

GET https://conductscience.org/api/trials/v1/NCT04470310/registered